OncoAlly® Common Hereditary Cancer Analysis
Use
The OncoAlly® Common Hereditary Cancer Analysis is designed to identify genetic variants associated with hereditary cancer. This test sequences and analyzes the entire gene for 62 genes associated with common hereditary cancer, allowing for the detection of all clinically relevant variant types including deletions, duplications, insertions, and inversions, with high specificity and sensitivity.
Special Instructions
Not provided.
Limitations
The OncoAlly® Common Hereditary Cancer Analysis does not fully cover the FOCAD gene, and there may be variants in certain regions of this gene that are not identified. In the non-unique regions of PMS2 (exons 13-15), sequence changes are generally detected, but structural variant sensitivity may be reduced.
Methodology
NGS (WGS)
Biomarkers
Result Turnaround Time
2-4 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
5ml
Minimum Volume
Not provided
Collection Instructions
Refer to Variantyx specimen requirements for blood.